PathoGenetiX (Woburn, MA) a development-stage diagnostic company focused on the identification of pathogenic bacterial strains, closed a $4M Series B financing. Participants include Excel Venture Management, CB Health Ventures and HealthCare Ventures.

Thanx for your patience as we catch-up.